Free Trial

Nihon Kohden Q3 2025 Earnings Report

Nihon Kohden logo
$15.34 -0.29 (-1.82%)
As of 02/21/2025 03:56 PM Eastern

Nihon Kohden EPS Results

Actual EPS
$0.30
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Nihon Kohden Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Nihon Kohden Announcement Details

Quarter
Q3 2025
Time
Before Market Opens

Conference Call Resources

Nihon Kohden Earnings Headlines

Do this Before Elon’s Reveal on March 17th
Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.
See More Nihon Kohden Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Nihon Kohden? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Nihon Kohden and other key companies, straight to your email.

About Nihon Kohden

Nihon Kohden (OTCMKTS:NHNKY) engages in development, manufacturing, sale, maintenance, and consultation of medical electronic equipment, and related systems and products in Japan, Americas, Europe, rest of Asia, and internationally. It offers physiological measuring equipment comprising electrocardiographs, electroencephalographs, and polygraphs for Cath-labs; patient monitoring systems, such as beside and central monitors; and treatment equipment including defibrillators, automated external defibrillators, ventilators, and pacemakers. The company also provides medical support system, which includes diagnostic and clinical information system; and in-vitro diagnostic equipment comprising hematology and clinical chemistry analyzers. In addition, it operates insurance brokerage and technology licensing business. The company was incorporated in 1951 and is headquartered in Shinjuku, Japan.

View Nihon Kohden Profile

More Earnings Resources from MarketBeat